– Collaboration will simplify providers’ and patients’ access to discrete test results that can inform more precise, personalized medicine – SAN FRANCISCO, March 21, 2023 /PRNewswire/ — Invitae (NYSE: NVTA), a leading medical genetics company, today announced its partnership with Epic,…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.